Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is aggressive primary malignancy of the liver that most commonly presents late in the disease course. As a result, the majority of patients are not candidates for curative therapies. Locoregional therapies including Yttrium-90 (Y-90) radioembolization play...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Gastrointest Oncol
Glavni autori: Bhangoo, Munveer Singh, Karnani, Diraj R., Hein, Paul N., Giap, Huan, Knowles, Harry, Issa, Chris, Steuterman, Steve, Pockros, Paul, Frenette, Catherine
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2015
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4570909/
https://ncbi.nlm.nih.gov/pubmed/26487939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2015.056
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items